mbs303MBS-303: CD20CD3Beijing Mabworks Biotech Co., Ltd. ()12MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. The